transferrin has been researched along with Carcinoma, Ductal, Pancreatic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caen, JD; Dacek, MM; Dilling, TR; Evans, MJ; Fox, IL; Henry, KE; Lewis, JS | 1 |
| Chen, J; Chen, L; Hu, L; Ma, X; Wu, W; Yang, R; Zhao, Y; Zhou, H | 1 |
| Jin, DY; Lin, C; Lou, WH; Wang, DS; Wu, WC; Zhao, GC | 1 |
| Hayashi, A; Ishigaki, Y; Motoo, Y; Shimasaki, T; Takata, T; Tomosugi, N; Tsuchida, H | 1 |
| Büchler, MW; Hartel, M; Huszty, G; Knaebel, HP; Ryschich, E; Schmidt, J | 1 |
5 other study(ies) available for transferrin and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Mitogen-Activated Protein Kinase 3; Molecular Targeted Therapy; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Radioisotopes; Signal Transduction; Transferrin; Zirconium | 2019 |
[Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
Topics: alpha-2-HS-Glycoprotein; Biomarkers; Biomarkers, Tumor; Blotting, Western; Carcinoma, Pancreatic Ductal; Complement C3; Electrophoresis, Gel, Two-Dimensional; Humans; Immunohistochemistry; Mass Spectrometry; Pancreatic Neoplasms; Pancreatitis, Chronic; Proteomics; Real-Time Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transferrin; Up-Regulation | 2014 |
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma.
Topics: Apolipoprotein A-I; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Transferrin | 2016 |
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.
Topics: 14-3-3 Proteins; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Gemcitabine; Humans; Lactoferrin; Neoplasm Proteins; Pancreatic Neoplasms; Proteomics; S100 Proteins; Transferrin | 2012 |
Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Topics: Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Flow Cytometry; Humans; Immunohistochemistry; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Receptors, Transferrin; Transferrin | 2004 |